10/26/2020 8:05:36 AM
PerkinElmer Gets CE Mark For PKamp Respiratory SARS-CoV-2 RT-PCR Panel
10/22/2020 4:21:43 PM
PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 1/22/2021
10/20/2020 9:05:55 AM
PerkinElmer: Research Team At NCATS Of NIH Is Working With Its AlphaLISA Immunoassay For Effective COVID-19 Therapeutics
10/12/2020 8:06:46 AM
PerkinElmer Expects Reported And Organic Revenue Growth Of About 35% And 33%, Respectively, For Q3
8/17/2020 10:48:22 AM
PerkinElmer Says Enhances Hand Sanitizer Analyzer To Detect Methanol In 30 Seconds Or Less
7/28/2020 4:19:53 PM
PerkinElmer Q2 EPS $1.23 Vs. $0.62 Year Ago
7/23/2020 4:24:27 PM
PerkinElmer Declares Quarterly Dividend Of $0.07/share, Payable Nov. 6/ Record Oct. 16
7/23/2020 4:23:07 PM
PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 10/16/2020
7/21/2020 8:06:28 AM
PerkinElmer Announces The Launch Of Dry Blood Spot Based Test For SARS-CoV-2 IgG
7/21/2020 8:04:15 AM
PerkinElmer Announces Launch Of A Dry Blood Spot Based Test For SARS-CoV-2 IgG
7/13/2020 8:04:19 AM
PerkinElmer Anticipates Growth In Both Reported Revenue And Organic Revenue Of 12% For Q2